| 发明名称 | Methods of intravenous administration of glyburide | ||
| 摘要 | The present disclosure is drawn to a method of treating a patient in need of treatment, comprising identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient at from about 15 μg/hr and about 300 μg/hr, wherein the continuous infusion glyburide is administered for a period of time more than about 20 hours. | ||
| 申请公布号 | US9561176(B2) | 申请公布日期 | 2017.02.07 |
| 申请号 | US201514878232 | 申请日期 | 2015.10.08 |
| 申请人 | Remedy Pharmaceuticals, Inc. | 发明人 | Jacobson Sven Martin |
| 分类号 | A61K31/17;A61K9/00;A61K31/64;A61K31/18 | 主分类号 | A61K31/17 |
| 代理机构 | Thorpe North & Western LLP | 代理人 | Thorpe North & Western LLP |
| 主权项 | 1. A method of treating a patient in need of treatment, comprising: identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient ranging from 15 μg/hr to 300 μg/hr, wherein the continuous infusion glyburide is administered for about 20 hours or more. | ||
| 地址 | New York NY US | ||